IMSCM2018, Amphithéâtre Constant Burg, Institut Curie
This meeting in a “workshop” style aimed to highlight the areas of research supported by the RADIATE consortium. We brought together internationally recognised leaders in the field, to interact with all attendees and the RADIATE students, to focus on current work in radiation biology.
Radiation therapy is a mainstay in cancer therapy, yet many patients still fail to fully benefit. The workshop was intended to aid the integration of radiobiology research and to “open doors” to essential research that has major implications for cancer therapy.
The invited speakers in the four categories were:
- TUMOUR MICROENVIRONMENT – Mark Dewhirst (Duke University, USA) and Ester Hammond (University of Oxford, UK)
- IMMUNE RESPONSE – Andy Minn (University of Pennsylvania, USA) and Mark de Ridder (Vrije Universiteit Brussel, Belgium)
- DNA REPAIR – Thomas Helleday (University of Sheffield Medical School, UK) and Marie Dutreix (Institut Curie, France)
- INNOVATIVE THERAPIES – Silvia Formenti (Weill Cornell Medical College, USA) and Rob Coppes (Groningen University Medical Center, The Netherlands)
With approximately 100 participants, many of them young researchers, from Europe, the USA and Canada, the IMSCM2018 proved to be a vibrant meeting and allowed a lively exchange of ideas in the field of radiation biology.
Both the meeting and the evening social event provided good opportunities for scientific exchanges and networking.
The RADIATE-ITN is grateful to the Institut Curie for allowing us to host our meeting in Orsay and Paris and all those who have contributed to make it possible.